Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $20.62 Analyst target: $19.00 Upside: -7.86%
Fulgent Genetics, Inc., provides COVID-19 testing and genetic testing services to physicians with clinically actionable diagnostic information. The company is headquartered in Temple City, California.
See the full interactive analysis & chart →Informational only — not investment advice.